Does caffeine consumption modify cerebrospinal fluid amyloid-β levels in patients with Alzheimer’s disease?

© 2015 – IOS Press and the authors. All rights reserved

Detalhes bibliográficos
Autor principal: Travassos, Maria (author)
Outros Autores: Santana, Isabel (author), Baldeiras, Inês (author), Tsolaki, Magda (author), Gkatzima, Olymbia (author), Sermin, Genc (author), Yener, Görsev G. (author), Simonsen, Anja (author), Hasselbalch, Steen G. (author), Kapaki, Elisabeth (author), Mara, Bourbouli (author), Cunha, Rodrigo A. (author), Agostinho, Paula (author), Blennow, Kaj (author), Zetterberg, Henrik (author), Mendes, Vera M. (author), Manadas, Bruno (author), De Mendonça, Alexandre (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Alzheimer’s disease
Amyloid-β
Biomarkers
Caffeine
Cerebrospinal fluid
Metabolism
Mild cognitive impairment
Phosphotau
Theobromine
Total tau
Texto completo:http://hdl.handle.net/10451/51777
País:Portugal
Oai:oai:repositorio.ul.pt:10451/51777
Descrição
Resumo:© 2015 – IOS Press and the authors. All rights reserved

Registos relacionados